Emodin is a Potential Drug Targeting CD44-positive Hepatocellular Cancer.

Yuan GaoYouling LiYunhe ZhuQiao LuoYifeng LuKe WenBoyu DuXueyan XiGang Li

Published in: Current cancer drug targets (2024)

Emodin shows promise as a potential therapeutic agent for HCC by targeting CD44-- positive hepatoma cells.

Keyphrases